Cytosorbents
CTSO
#9825
Rank
S$59.42 M
Marketcap
S$0.95
Share price
-1.20%
Change (1 day)
-24.00%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -S$15.53 Million

According to Cytosorbents's latest financial reports the company's current earnings are S$36.1 Million. In 2024 the company made an earning of -S$28.89 Million, an increase over its 2023 earnings that were of -S$38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$15.53 Million-46.25%
2024 -S$28.89 Million-23.97%
2023 -S$38 Million-13.52%
2022 -S$43.94 Million34.04%
2021 -S$32.78 Million182.17%
2020 -S$11.62 Million-55.97%
2019 -S$26.39 Million14.17%
2018 -S$23.11 Million95.14%
2017 -S$11.85 Million-22.32%
2016 -S$15.25 Million39.1%
2015 -S$10.96 Million-12.89%
2014 -S$12.58 Million89%
2013 -S$6.66 Million26.65%
2012 -S$5.26 Million-26.02%
2011 -S$7.11 Million-288.45%
2010 S$3.76 M-4.17%
2009 S$3.93 M-287.19%
2008 -S$2.11 Million-47.12%
2007 -S$3.98 Million41.78%
2006 -S$2.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
S$71.93 M-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$1.03 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
S$4.23 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA